
As of the company’s announcement, Manitoba is the only province in Canada that does not require an application for coverage preapproval. That means improved access for patients and a reduced workload for prescribers.
Expanded coverage establishes Manitoba as the leader in coverage for real-time continuous glucose monitoring (rtCGM) among Canadian provinces.
Get the full story at our sister site, Drug Delivery Business News.